Conferences Wave Life Sciences is attending in 2026

wavelifesciences.com

Wave Life Sciences is listed at 2 conferences on Tnuki's calendar in 2026: ESGCT 2026 (on the program) and TIDES Europe 2026 (on the program). Wave Life Sciences develops RNA medicines targeting genetic diseases through oligonucleotide therapeutics and gene editing. As of Oct 17, 2026.

ConferenceDetailsInvolvementTnuki guide
ESGCT 33rd Annual CongressEurope’s gene & cell therapy researchersOfficial site
Hamburg, Germany ~2.5k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 oral abstract
Attending
  • speaker
Attendee mix: Mostly academic; gene and cell therapy PIs, postdocs and clinicians, strong biotech and CDMO presence
Open the guide Search and filter attendees
TIDES Europe 2026: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site
Amsterdam, Netherlands ~900 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 talks
Attending
  • Vice President, Medicinal Chemistry
  • Vice President, Oligonucleotide Synthesis and Chemistry
Attendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Wave Life Sciences’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Wave Life Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →